CEO SUMMARY: One after another, a series of breaking news stories points to more rough waters ahead for the entire clinical lab industry. Of greatest interest is the ongoing questions about when clinical labs and pathology groups will get paid for the molecular test claims they have submitted to government and private payers since January …
Big Lab Industry Stories Reveal Trouble Ahead Read More »
To access this post, you must purchase The Dark Report.